StockMacro
Company, fund or insider

Help

Menu

Alector

$2.33 +6.6% in 6 monthsMarket cap $347.6M

ALEC on XNAS, Health Care, Alector, Inc., job postings

Measures activity, not value. Not investment advice.

Revenue rose 151% to $173.5M over 12 months but short interest doubled to 10.3M shares.

  • GoodShares up 95% in 12 months and 25% in one month

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.

Industry
Biological products, (no diagnostic substances) (Health Care)
Employees
103
Website
alector.com
Listed
Nasdaq, US
Last results
5 Nov 2026
Next results
expected around 24 Feb 2027 (an estimate: a year ago it reported on 25 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $162.9M, net income $124.6M.
Quarter to 31 Dec 2021: revenue $14.0M, net income -$55.6MQuarter to 31 Dec 2021: revenue $14.0M, net income -$55.6MQuarter to 31 Mar 2022: revenue $24.5M, net income -$44.6MQuarter to 31 Mar 2022: revenue $24.5M, net income -$44.6MQuarter to 30 Jun 2022: revenue $79.9M, net income $9.9MQuarter to 30 Jun 2022: revenue $79.9M, net income $9.9MQuarter to 30 Sep 2022: revenue $14.9M, net income -$46.1MQuarter to 30 Sep 2022: revenue $14.9M, net income -$46.1MQuarter to 31 Dec 2022: revenue $14.4M, net income -$52.4MQuarter to 31 Dec 2022: revenue $14.4M, net income -$52.4MQuarter to 31 Mar 2023: revenue $16.5M, net income -$45.9MQuarter to 31 Mar 2023: revenue $16.5M, net income -$45.9MQuarter to 30 Jun 2023: revenue $56.2M, net income $1.4MQuarter to 30 Jun 2023: revenue $56.2M, net income $1.4MQuarter to 30 Sep 2023: revenue $9.1M, net income -$44.5MQuarter to 30 Sep 2023: revenue $9.1M, net income -$44.5MQuarter to 31 Dec 2023: revenue $15.2M, net income -$41.4MQuarter to 31 Dec 2023: revenue $15.2M, net income -$41.4MQuarter to 31 Mar 2024: revenue $15.9M, net income -$36.1MQuarter to 31 Mar 2024: revenue $15.9M, net income -$36.1MQuarter to 30 Jun 2024: revenue $15.1M, net income -$38.7MQuarter to 30 Jun 2024: revenue $15.1M, net income -$38.7MQuarter to 30 Sep 2024: revenue $15.3M, net income -$42.2MQuarter to 30 Sep 2024: revenue $15.3M, net income -$42.2MQuarter to 31 Dec 2024: revenue –, net income -$2.1MQuarter to 31 Mar 2025: revenue $3.7M, net income -$40.5MQuarter to 31 Mar 2025: revenue $3.7M, net income -$40.5MQuarter to 30 Jun 2025: revenue $7.9M, net income -$30.5MQuarter to 30 Jun 2025: revenue $7.9M, net income -$30.5MQuarter to 30 Sep 2025: revenue $3.3M, net income -$34.7MQuarter to 30 Sep 2025: revenue $3.3M, net income -$34.7MQuarter to 31 Dec 2025: revenue $6.2M, net income -$37.3MQuarter to 31 Dec 2025: revenue $6.2M, net income -$37.3MQuarter to 31 Mar 2026: revenue $1.0M, net income -$22.9MQuarter to 31 Mar 2026: revenue $1.0M, net income -$22.9MQuarter to 30 Jun 2026: revenue $3.3M, net income -$23.0MQuarter to 30 Jun 2026: revenue $3.3M, net income -$23.0MQuarter to 30 Sep 2026: revenue $162.9M, net income $124.6MQuarter to 30 Sep 2026: revenue $162.9M, net income $124.6M
31 Dec 2021RevenueNet incomeNet losstallest bar $162.9M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$162.9M$124.6M
30 Jun 2026$3.3M-$23.0M
31 Mar 2026$1.0M-$22.9M
31 Dec 2025$6.2M-$37.3M
30 Sep 2025$3.3M-$34.7M
30 Jun 2025$7.9M-$30.5M
31 Mar 2025$3.7M-$40.5M
31 Dec 2024–-$2.1M
30 Sep 2024$15.3M-$42.2M
30 Jun 2024$15.1M-$38.7M
31 Mar 2024$15.9M-$36.1M
31 Dec 2023$15.2M-$41.4M
30 Sep 2023$9.1M-$44.5M
30 Jun 2023$56.2M$1.4M
31 Mar 2023$16.5M-$45.9M
31 Dec 2022$14.4M-$52.4M
30 Sep 2022$14.9M-$46.1M
30 Jun 2022$79.9M$9.9M
31 Mar 2022$24.5M-$44.6M
31 Dec 2021$14.0M-$55.6M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $173.5M $69.0M
Revenue growthRevenue of the last 12 months compared with the 12 months before. +151% +8.2%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $41.4M -$107.7M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $0.35 -$1.06
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 70.4%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 20.2% -179% -98.6%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 23.9% -156% -47.8%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 47.5% -58.2%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – -$197.6M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $138.7M $291.1M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. – $9.6M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). – -$281.5M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. – 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $0.78
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 8.4 21.6
P/SPrice to sales: market cap divided by revenue of the last 12 months. 2.0 8.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 6.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 3.0 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
AlectorALEC (this company) $347.6M8.42.0+151%23.9%
C4 TherapeuticsCCCC $325.7Mloss10.1+7.2%-282%
X4 PharmaceuticalsXFOR $306.3Mloss18.1-50%-475%
Candel TherapeuticsCADL $395.4Mloss–––
TevogenTVGN $405.2Mloss–––
Tectonic TherapeuticTECX $405.3Mloss–––

Insider buy/sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$296K

bought $0, sold $296K

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-2.2%

136 13F filers vs 139

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

64%

95.0M shares held by 13F filers (30 Sep 2026) of 148.9M outstanding (30 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

5.6%

8.4M shares sold short (30 Oct 2026) of 148.9M outstanding (30 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

3.6

8.4M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-18%

10.3M shares sold short in the report before, 8.4M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

54%

54% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 46%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

4

Tracked since 20 Nov 2026

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

Tracking started 20 Nov 2026; the change shows after 30 days.

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

4

4 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

–

4 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.

Unusual now sharp changes in the last 90 days, compared with its own past

  • Revenue $162.9M, 50× a year earlier
  • Short interest 10.3M, 2.0× a year earlier

Price $2.33 on 20 Nov 2026, +95% over 12 months (12-month range $1.14 to $2.72)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $1.0M in the last 12 months (the 12 months before: -$831K).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 0 published in the last 12 months, -100% on the 12 months before.
Revenue per quarter. Revenue $162.9M in the latest quarter, +4896% on a year earlier.
Capital spending per quarter. Capital spending $31K in the latest quarter, +210% on a year earlier.
Institutional holders (13F filers). 136 13F filers reported holding it in the latest 13F quarter, -4.2% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
17 Nov 2026Sharp changeShort interest spike: short interest spike, 8.4M vs usual 6.0M (2026-10-30); 1.8x the same period a year earlier
10 Nov 2026Sharp changeQuarterly revenue change: quarterly revenue change, 162.9M vs usual 5.0M (2026-09-30); 50.0x the same period a year earlier
27 Oct 2026Sharp changeShort interest spike: short interest spike, 10.3M vs usual 5.8M (2026-10-15); 2.0x the same period a year earlier
14 Oct 20268-K and other filingsDirector or officer change
14 Oct 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
8 Jul 20268-K and other filingsA major agreement ended
12 Dec 20258-K and other filingsDirector or officer change
21 Oct 20258-K and other filingsDirector or officer change
21 Oct 20258-K and other filingsRestructuring costs announced
21 Oct 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
13 Jun 20258-K and other filingsDirector or officer change
13 May 2025Sharp changeQuarterly revenue change: quarterly revenue change, 3.7M vs usual 15.6M (2025-03-31); 0.2x the same period a year earlier
28 Mar 20258-K and other filingsDirector or officer change
28 Mar 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
10 Mar 20258-K and other filingsRestructuring costs announced
4 Mar 2025Sharp changeQuarterly revenue change: quarterly revenue change, 54.2M vs usual 15.3M (2024-12-31); 3.6x the same period a year earlier
25 Nov 20248-K and other filingsRestructuring costs announced
18 Jun 2024Sharp changeShort interest spike: short interest spike, 8.6M vs usual 6.1M (2024-05-31); 1.4x the same period a year earlier
21 Mar 20248-K and other filingsDirector or officer change
21 Mar 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
27 Apr 20238-K and other filingsDirector or officer change
27 Apr 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
29 Mar 20238-K and other filingsRestructuring costs announced
5 Oct 20228-K and other filingsDirector or officer change
23 Sep 20228-K and other filingsDirector or officer change
23 Sep 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
9 Aug 2022Sharp changeQuarterly revenue change: quarterly revenue change, 79.9M vs usual 6.2M (2022-06-30); 12.2x the same period a year earlier
10 May 2022Sharp changeQuarterly revenue change: quarterly revenue change, 24.5M vs usual 6.2M (2022-03-31); 6.0x the same period a year earlier
29 Mar 20228-K and other filingsDirector or officer change
1 Mar 2022Sharp changeQuarterly revenue change: quarterly revenue change, 14.0M vs usual 6.0M (2021-12-31); 2.9x the same period a year earlier
7 Feb 20228-K and other filingsDirector or officer change
3 Jan 20228-K and other filingsDirector or officer change
3 Jan 20228-K and other filingsDirector or officer change
15 Dec 20218-K and other filingsDirector or officer change
Insider net buying (open market)
Month from 1 Dec 2021: -$6.7M published
Month from 1 Mar 2022: -$4K published
Month from 1 Jun 2022: -$2K published
Month from 1 Sep 2022: -$25K published
Month from 1 Mar 2023: -$284K published
Month from 1 Jun 2023: -$90K published
Month from 1 Sep 2023: -$3.1M published
Month from 1 Dec 2023: -$256K published
Month from 1 Mar 2024: -$282K published
Month from 1 Jun 2024: -$256K published
Month from 1 Aug 2024: -$307K published
Month from 1 Sep 2024: -$274K published
Month from 1 Dec 2024: -$277K published
Month from 1 Mar 2025: -$153K published
Month from 1 Jun 2025: -$125K published
Month from 1 Aug 2025: -$33K published
Month from 1 Sep 2025: -$242K published
Month from 1 Dec 2025: -$220K published
Month from 1 Feb 2026: -$10K published
Month from 1 Mar 2026: -$263K published
Month from 1 Apr 2026: -$5K published
Month from 1 Jun 2026: -$228K published
Month from 1 Sep 2026: -$296K published
H-1B/E-3 applications certified
Quarter from 1 Jan 2022: 1 published
Quarter from 1 Apr 2022: 1 published
Quarter from 1 Jul 2022: 2 published
Quarter from 1 Jan 2023: 1 published
Quarter from 1 Apr 2023: 4 published
Quarter from 1 Oct 2023: 1 published
Quarter from 1 Oct 2024: 1 published
Quarter from 1 Jan 2025: 1 published
Revenue per quarter
Quarter ended 31 Dec 2021: $14.0M, +188% on a year earlier; public on 25 Feb 2022
Quarter ended 31 Mar 2022: $24.5M, +495% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $79.9M, +1116% on a year earlier; public on 5 Aug 2022
Quarter ended 30 Sep 2022: $14.9M, -92% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $14.4M, +3.2% on a year earlier; public on 1 Mar 2023
Quarter ended 31 Mar 2023: $16.5M, -32% on a year earlier; public on 5 May 2023
Quarter ended 30 Jun 2023: $56.2M, -30% on a year earlier; public on 4 Aug 2023
Quarter ended 30 Sep 2023: $9.1M, -39% on a year earlier; public on 8 Nov 2023
Quarter ended 31 Dec 2023: $15.2M, +5.2% on a year earlier; public on 28 Feb 2024
Quarter ended 31 Mar 2024: $15.9M, -4.0% on a year earlier; public on 9 May 2024
Quarter ended 30 Jun 2024: $15.1M, -73% on a year earlier; public on 8 Aug 2024
Quarter ended 30 Sep 2024: $15.3M, +68% on a year earlier; public on 7 Nov 2024
Quarter ended 31 Mar 2025: $3.7M, -77% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $7.9M, -48% on a year earlier; public on 8 Aug 2025
Quarter ended 30 Sep 2025: $3.3M, -79% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $6.2M; public on 26 Feb 2026
Quarter ended 31 Mar 2026: $1.0M, -72% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $3.3M, -58% on a year earlier; public on 7 Aug 2026
Quarter ended 30 Sep 2026: $162.9M, +4896% on a year earlier; public on 6 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $557K, -29% on a year earlier; public on 25 Feb 2022
Quarter ended 31 Mar 2022: $692K, -27% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $744K, -10% on a year earlier; public on 5 Aug 2022
Quarter ended 30 Sep 2022: $1.9M, +109% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $766K, +38% on a year earlier; public on 1 Mar 2023
Quarter ended 31 Mar 2023: $1.0M, +48% on a year earlier; public on 5 May 2023
Quarter ended 30 Jun 2023: $1.2M, +64% on a year earlier; public on 4 Aug 2023
Quarter ended 31 Dec 2023: $233K, -70% on a year earlier; public on 28 Feb 2024
Quarter ended 31 Mar 2024: $533K, -48% on a year earlier; public on 9 May 2024
Quarter ended 30 Jun 2024: $337K, -72% on a year earlier; public on 8 Aug 2024
Quarter ended 30 Sep 2024: $212K; public on 7 Nov 2024
Quarter ended 31 Dec 2024: $173K, -26% on a year earlier; public on 27 Feb 2025
Quarter ended 31 Mar 2025: $20K, -96% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $10K, -97% on a year earlier; public on 8 Aug 2025
Quarter ended 30 Sep 2025: $11K, -95% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Mar 2026: $118K, +490% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $31K, +210% on a year earlier; public on 7 Aug 2026
Institutional holders (13F filers)
31 Dec 2021 report: 151; public on 14 Feb 2022
31 Mar 2022 report: 155; public on 16 May 2022
30 Jun 2022 report: 143; public on 15 Aug 2022
30 Sep 2022 report: 151; public on 14 Nov 2022
31 Dec 2022 report: 141; public on 14 Feb 2023
31 Mar 2023 report: 137; public on 15 May 2023
30 Jun 2023 report: 135; public on 14 Aug 2023
30 Sep 2023 report: 136; public on 14 Nov 2023
31 Dec 2023 report: 139; public on 14 Feb 2024
31 Mar 2024 report: 152; public on 15 May 2024
30 Jun 2024 report: 147; public on 14 Aug 2024
30 Sep 2024 report: 156; public on 14 Nov 2024
31 Dec 2024 report: 146; public on 14 Feb 2025
31 Mar 2025 report: 137; public on 15 May 2025
30 Jun 2025 report: 131; public on 14 Aug 2025
30 Sep 2025 report: 142; public on 14 Nov 2025
31 Dec 2025 report: 123; public on 17 Feb 2026
31 Mar 2026 report: 132; public on 15 May 2026
30 Jun 2026 report: 139; public on 14 Aug 2026
30 Sep 2026 report: 136; public on 16 Nov 2026

What is unusual now

  • Made public in the last 90 days: it reported revenue of $162.9M for the quarter ended 30 Sep 2026, 50× the same quarter last year; it also had 10.3M shares sold short in the 15 Oct 2026 report, 2.0× the same report last year. 3 sharp changes in all. Two or more unrelated kinds of activity agreed on 10 Nov 2026.
  • Quarterly revenue change: reported revenue of $162.9M for the quarter ended 30 Sep 2026, 50× the same quarter last year Public on 10 Nov 2026.
  • Short interest spike: had 10.3M shares sold short in the 15 Oct 2026 report, 2.0× the same report last year Public on 27 Oct 2026.
  • Insider net buying (open market): Insiders sold a net $1.0M in the last 12 months (the 12 months before: -$831K).

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 3 sales, $296K; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
4 Sep 2026Arnon RosenthalChief Executive OfficerSell72,606$2.66$193KForm 4
4 Sep 2026Neil Lindsay BerkleyCFO & Chief Business OfficerSell29,251$2.66$78KForm 4
4 Sep 2026Grace Wong-SaradPrincipal Accounting OfficerSell9,446$2.61$25KForm 4
3 Jun 2026Grace Wong-SaradPrincipal Accounting OfficerSell9,184$1.94$18KForm 4
3 Jun 2026Neil Lindsay BerkleyCFO & Chief Business OfficerSell19,360$1.97$38KForm 4
3 Jun 2026Arnon RosenthalChief Executive OfficerSell87,216$1.97$172KForm 4
17 Apr 2026Grace Wong-SaradPrincipal Accounting OfficerSellplanned in advance (10b5-1)1,820$2.65$5KForm 4
12 Mar 2026Grace Wong-SaradPrincipal Accounting OfficerSellplanned in advance (10b5-1)1,000$2.65$3KForm 4

136 institutions reported shares at the end of Q3 2026, 64% of the shares outstanding; 13 opened a position, 18 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BVF Inc10.0M6.75%$18.6MNew+10.0M
TCG Crossover Management, LLC10.0M6.72%$18.5MNo change
BlackRock, Inc.7.7M5.17%$14.2M-149K-1.9%
Acadian Asset Management LLC4.5M3.00%+47K+1.1%
Nantahala Capital Management, LLC4.3M2.90%$8.0M-4.3M-50%
Kynam Capital Management, LP4.3M2.89%$8.0M+500K+13%
Vanguard Capital Management LLC4.0M2.69%$7.4M+1,2000%
Merck & Co., Inc.3.5M2.38%$6.6MNo change
Millennium Management LLC3.0M2.05%$5.6M+1.1M+53%
Vanguard Portfolio Management LLC2.7M1.80%$5.0M-143K-5.1%

Company events

All 44 company events

In 12 months: 3 major agreements, 2 director or officer changes, 1 agreement ended. Results releases and routine reports are left out.

FiledWhat happenedSource
16 Oct 2026Signed a major agreement8-K
14 Oct 2026Director or officer change8-K
5 Oct 2026Signed a major agreement8-K
8 Jul 2026A major agreement ended8-K
7 May 2026Signed a major agreement8-K
12 Dec 2025Director or officer change8-K
21 Oct 2025Director or officer change; Restructuring costs announced8-K
13 Jun 2025Director or officer changeSame filing: shareholder vote results8-K

4 open postings; careers site tracked since 20 Nov 2026. Most in Research & science 50%, Operations & administration 25%, Program & project management 25%.

PostedJobLocation
19 Nov 2026Senior Staff Scientist, Oligonucleotide EngineeringResearch & scienceSouth San Francisco, CA
2 Sep 2026(Senior) Associate Scientist, Bioanalytical SciencesResearch & scienceSouth San Francisco, CA
25 Aug 2026Vice President, Clinical DevelopmentOperations & administrationUnited States
28 Jul 2026Associate Director, Project Management (Temporary)Program & project managementSouth San Francisco, CA

The 5 newest of 76 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

10 Nov 2026confirmed

Confirmed across sources Filings + Financials and Short interest and volume

Alector (ALEC): had 10.3M shares sold short in the 15 Oct 2026 report, 2.0× the same report last year, while it reported revenue of $162.9M for the quarter ended 30 Sep 2026, 50× the same quarter last year. Two unrelated kinds of activity within 21 days.

  • Short interest and volume: Short interest spike, became public on 27 Oct 2026
  • Financials: Quarterly revenue change, became public on 10 Nov 2026
  • Short interest and volume: Short interest spike, became public on 11 Nov 2026
2025-10-15: 5.2M2025-10-31: 4.6M2025-11-14: 5.4M2025-11-28: 4.7M2025-12-15: 6.3M2025-12-31: 6.1M2026-01-15: 6.5M2026-01-30: 6.5M2026-02-13: 6.1M2026-02-27: 6.0M2026-03-13: 6.0M2026-03-31: 6.3M2026-04-15: 5.2M2026-04-30: 5.0M2026-05-15: 4.9M2026-05-29: 5.1M2026-06-15: 5.2M2026-06-30: 5.7M2026-07-15: 5.7M2026-07-31: 5.6M2026-08-14: 5.9M2026-08-31: 6.2M2026-09-15: 6.1M2026-09-30: 6.1M2026-10-15: 10.3M
The 15 Oct 2026 report against the 24 reports before it. this reportearliernormal: 5.8M
See the evidence (3 changes)

Short interest and volume: Short interest spike became public on 27 Oct 2026

Alector had 10.3M shares sold short in the 15 Oct 2026 report, 2.0× the same report last year.

This period
10.3M (the 15 Oct 2026 report)
Normal report (median of 24 earlier)
5.8M
Typical spread (median absolute deviation)
430K
How far from its usual level
+7.0
Same report last year
5.2M
History used
2,799 days
2025-10-15: 5.2M2025-10-31: 4.6M2025-11-14: 5.4M2025-11-28: 4.7M2025-12-15: 6.3M2025-12-31: 6.1M2026-01-15: 6.5M2026-01-30: 6.5M2026-02-13: 6.1M2026-02-27: 6.0M2026-03-13: 6.0M2026-03-31: 6.3M2026-04-15: 5.2M2026-04-30: 5.0M2026-05-15: 4.9M2026-05-29: 5.1M2026-06-15: 5.2M2026-06-30: 5.7M2026-07-15: 5.7M2026-07-31: 5.6M2026-08-14: 5.9M2026-08-31: 6.2M2026-09-15: 6.1M2026-09-30: 6.1M2026-10-15: 10.3M
the 15 Oct 2026 report24 earlier reportsnormal: 5.8M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Financials: Quarterly revenue change became public on 10 Nov 2026

Alector reported revenue of $162.9M for the quarter ended 30 Sep 2026, 50× the same quarter last year.

This period
$162.9M (the quarter ended 30 Sep 2026)
Normal quarter (median of 8 earlier)
$5.0M
Typical spread (median absolute deviation)
$2.3M
How far from its usual level
+46.2
Same quarter last year
$3.3M
History used
3,105 days
2024-09-30: $15.3M2024-12-31: $54.2M2025-03-31: $3.7M2025-06-30: $7.9M2025-09-30: $3.3M2025-12-31: $6.2M2026-03-31: $1.0M2026-06-30: $3.3M2026-09-30: $162.9M
the quarter ended 30 Sep 20268 earlier quartersnormal: $5.0M

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

Check it at the source: SEC EDGAR quarterly reports.

Short interest and volume: Short interest spike became public on 11 Nov 2026

Alector had 8.4M shares sold short in the 30 Oct 2026 report, 1.8× the same report last year.

This period
8.4M (the 30 Oct 2026 report)
Normal report (median of 24 earlier)
6.0M
Typical spread (median absolute deviation)
350K
How far from its usual level
+4.1
Same report last year
4.6M
History used
2,814 days
2025-10-31: 4.6M2025-11-14: 5.4M2025-11-28: 4.7M2025-12-15: 6.3M2025-12-31: 6.1M2026-01-15: 6.5M2026-01-30: 6.5M2026-02-13: 6.1M2026-02-27: 6.0M2026-03-13: 6.0M2026-03-31: 6.3M2026-04-15: 5.2M2026-04-30: 5.0M2026-05-15: 4.9M2026-05-29: 5.1M2026-06-15: 5.2M2026-06-30: 5.7M2026-07-15: 5.7M2026-07-31: 5.6M2026-08-14: 5.9M2026-08-31: 6.2M2026-09-15: 6.1M2026-09-30: 6.1M2026-10-15: 10.3M2026-10-30: 8.4M
the 30 Oct 2026 report24 earlier reportsnormal: 6.0M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 11 Nov 2026Short interest and volume change

    had 8.4M shares sold short in the 30 Oct 2026 report, 1.8× the same report last year.

    Same report last year: 4.6M; its normal report is 6.0M.

    See the evidence
    This period
    8.4M (the 30 Oct 2026 report)
    Normal report (median of 24 earlier)
    6.0M
    Typical spread (median absolute deviation)
    350K
    How far from its usual level
    +4.1
    Same report last year
    4.6M
    History used
    2,814 days
    2025-10-31: 4.6M2025-11-14: 5.4M2025-11-28: 4.7M2025-12-15: 6.3M2025-12-31: 6.1M2026-01-15: 6.5M2026-01-30: 6.5M2026-02-13: 6.1M2026-02-27: 6.0M2026-03-13: 6.0M2026-03-31: 6.3M2026-04-15: 5.2M2026-04-30: 5.0M2026-05-15: 4.9M2026-05-29: 5.1M2026-06-15: 5.2M2026-06-30: 5.7M2026-07-15: 5.7M2026-07-31: 5.6M2026-08-14: 5.9M2026-08-31: 6.2M2026-09-15: 6.1M2026-09-30: 6.1M2026-10-15: 10.3M2026-10-30: 8.4M
    the 30 Oct 2026 report24 earlier reportsnormal: 6.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  2. 10 Nov 2026several at once

    had 10.3M shares sold short in the 15 Oct 2026 report, 2.0× the same report last year, while it reported revenue of $162.9M for the quarter ended 30 Sep 2026, 50× the same quarter last year. Two unrelated kinds of activity within 21 days.

    See the evidence (3 changes)

    Short interest and volume: Short interest spike became public on 27 Oct 2026

    Alector had 10.3M shares sold short in the 15 Oct 2026 report, 2.0× the same report last year.

    This period
    10.3M (the 15 Oct 2026 report)
    Normal report (median of 24 earlier)
    5.8M
    Typical spread (median absolute deviation)
    430K
    How far from its usual level
    +7.0
    Same report last year
    5.2M
    History used
    2,799 days
    2025-10-15: 5.2M2025-10-31: 4.6M2025-11-14: 5.4M2025-11-28: 4.7M2025-12-15: 6.3M2025-12-31: 6.1M2026-01-15: 6.5M2026-01-30: 6.5M2026-02-13: 6.1M2026-02-27: 6.0M2026-03-13: 6.0M2026-03-31: 6.3M2026-04-15: 5.2M2026-04-30: 5.0M2026-05-15: 4.9M2026-05-29: 5.1M2026-06-15: 5.2M2026-06-30: 5.7M2026-07-15: 5.7M2026-07-31: 5.6M2026-08-14: 5.9M2026-08-31: 6.2M2026-09-15: 6.1M2026-09-30: 6.1M2026-10-15: 10.3M
    the 15 Oct 2026 report24 earlier reportsnormal: 5.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Financials: Quarterly revenue change became public on 10 Nov 2026

    Alector reported revenue of $162.9M for the quarter ended 30 Sep 2026, 50× the same quarter last year.

    This period
    $162.9M (the quarter ended 30 Sep 2026)
    Normal quarter (median of 8 earlier)
    $5.0M
    Typical spread (median absolute deviation)
    $2.3M
    How far from its usual level
    +46.2
    Same quarter last year
    $3.3M
    History used
    3,105 days
    2024-09-30: $15.3M2024-12-31: $54.2M2025-03-31: $3.7M2025-06-30: $7.9M2025-09-30: $3.3M2025-12-31: $6.2M2026-03-31: $1.0M2026-06-30: $3.3M2026-09-30: $162.9M
    the quarter ended 30 Sep 20268 earlier quartersnormal: $5.0M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

    Short interest and volume: Short interest spike became public on 11 Nov 2026

    Alector had 8.4M shares sold short in the 30 Oct 2026 report, 1.8× the same report last year.

    This period
    8.4M (the 30 Oct 2026 report)
    Normal report (median of 24 earlier)
    6.0M
    Typical spread (median absolute deviation)
    350K
    How far from its usual level
    +4.1
    Same report last year
    4.6M
    History used
    2,814 days
    2025-10-31: 4.6M2025-11-14: 5.4M2025-11-28: 4.7M2025-12-15: 6.3M2025-12-31: 6.1M2026-01-15: 6.5M2026-01-30: 6.5M2026-02-13: 6.1M2026-02-27: 6.0M2026-03-13: 6.0M2026-03-31: 6.3M2026-04-15: 5.2M2026-04-30: 5.0M2026-05-15: 4.9M2026-05-29: 5.1M2026-06-15: 5.2M2026-06-30: 5.7M2026-07-15: 5.7M2026-07-31: 5.6M2026-08-14: 5.9M2026-08-31: 6.2M2026-09-15: 6.1M2026-09-30: 6.1M2026-10-15: 10.3M2026-10-30: 8.4M
    the 30 Oct 2026 report24 earlier reportsnormal: 6.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  3. 10 Nov 2026Financials change

    reported revenue of $162.9M for the quarter ended 30 Sep 2026, 50× the same quarter last year.

    Same quarter last year: $3.3M; its normal quarter is $5.0M.

    See the evidence
    This period
    $162.9M (the quarter ended 30 Sep 2026)
    Normal quarter (median of 8 earlier)
    $5.0M
    Typical spread (median absolute deviation)
    $2.3M
    How far from its usual level
    +46.2
    Same quarter last year
    $3.3M
    History used
    3,105 days
    2024-09-30: $15.3M2024-12-31: $54.2M2025-03-31: $3.7M2025-06-30: $7.9M2025-09-30: $3.3M2025-12-31: $6.2M2026-03-31: $1.0M2026-06-30: $3.3M2026-09-30: $162.9M
    the quarter ended 30 Sep 20268 earlier quartersnormal: $5.0M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  4. 27 Oct 2026Short interest and volume change

    had 10.3M shares sold short in the 15 Oct 2026 report, 2.0× the same report last year.

    Same report last year: 5.2M; its normal report is 5.8M.

    See the evidence
    This period
    10.3M (the 15 Oct 2026 report)
    Normal report (median of 24 earlier)
    5.8M
    Typical spread (median absolute deviation)
    430K
    How far from its usual level
    +7.0
    Same report last year
    5.2M
    History used
    2,799 days
    2025-10-15: 5.2M2025-10-31: 4.6M2025-11-14: 5.4M2025-11-28: 4.7M2025-12-15: 6.3M2025-12-31: 6.1M2026-01-15: 6.5M2026-01-30: 6.5M2026-02-13: 6.1M2026-02-27: 6.0M2026-03-13: 6.0M2026-03-31: 6.3M2026-04-15: 5.2M2026-04-30: 5.0M2026-05-15: 4.9M2026-05-29: 5.1M2026-06-15: 5.2M2026-06-30: 5.7M2026-07-15: 5.7M2026-07-31: 5.6M2026-08-14: 5.9M2026-08-31: 6.2M2026-09-15: 6.1M2026-09-30: 6.1M2026-10-15: 10.3M
    the 15 Oct 2026 report24 earlier reportsnormal: 5.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  5. 14 Oct 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  6. 14 Oct 2026Filings record

    Director or officer change

  7. 8 Jul 2026Filings record

    A major agreement ended

  8. 12 Dec 2025Filings record

    Director or officer change

  9. 21 Oct 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  10. 21 Oct 2025Filings record

    Director or officer change

  11. 21 Oct 2025Filings record

    Restructuring costs announced

  12. 13 Jun 2025Filings record

    Director or officer change

  13. 13 May 2025Financials change

    reported revenue of $3.7M for the quarter ended 31 Mar 2025, 77% below the same quarter last year.

    Same quarter last year: $15.9M; its normal quarter is $15.6M.

    See the evidence
    This period
    $3.7M (the quarter ended 31 Mar 2025)
    Normal quarter (median of 8 earlier)
    $15.6M
    Typical spread (median absolute deviation)
    $733K
    How far from its usual level
    -7.6
    Same quarter last year
    $15.9M
    History used
    2,557 days
    2023-03-31: $16.5M2023-06-30: $56.2M2023-09-30: $9.1M2023-12-31: $15.2M2024-03-31: $15.9M2024-06-30: $15.1M2024-09-30: $15.3M2024-12-31: $54.2M2025-03-31: $3.7M
    the quarter ended 31 Mar 20258 earlier quartersnormal: $15.6M

    Fires when the period is at least 3.0 robust standard deviations away from the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  14. 28 Mar 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  15. 28 Mar 2025Filings record

    Director or officer change

  16. 10 Mar 2025Filings record

    Restructuring costs announced

  17. 4 Mar 2025Financials change

    reported revenue of $54.2M for the quarter ended 31 Dec 2024, 3.6× the same quarter last year.

    Same quarter last year: $15.2M; its normal quarter is $15.3M.

    See the evidence
    This period
    $54.2M (the quarter ended 31 Dec 2024)
    Normal quarter (median of 8 earlier)
    $15.3M
    Typical spread (median absolute deviation)
    $726K
    How far from its usual level
    +25.5
    Same quarter last year
    $15.2M
    History used
    2,467 days
    2022-12-31: $14.4M2023-03-31: $16.5M2023-06-30: $56.2M2023-09-30: $9.1M2023-12-31: $15.2M2024-03-31: $15.9M2024-06-30: $15.1M2024-09-30: $15.3M2024-12-31: $54.2M
    the quarter ended 31 Dec 20248 earlier quartersnormal: $15.3M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  18. 25 Nov 2024Filings record

    Restructuring costs announced

  19. 12 Jun 2024Short interest and volume change

    had 8.6M shares sold short in the 31 May 2024 report, 1.4× the same report last year.

    Same report last year: 6.3M; its normal report is 6.1M.

    See the evidence
    This period
    8.6M (the 31 May 2024 report)
    Normal report (median of 24 earlier)
    6.1M
    Typical spread (median absolute deviation)
    426K
    How far from its usual level
    +3.9
    Same report last year
    6.3M
    History used
    1,932 days
    2023-05-31: 6.3M2023-06-15: 6.0M2023-06-30: 5.9M2023-07-14: 5.9M2023-07-31: 5.7M2023-08-15: 6.3M2023-08-31: 6.1M2023-09-15: 6.1M2023-09-29: 6.9M2023-10-13: 7.4M2023-10-31: 7.7M2023-11-15: 7.2M2023-11-30: 6.2M2023-12-15: 5.7M2023-12-29: 5.7M2024-01-12: 5.4M2024-01-31: 5.1M2024-02-15: 5.2M2024-02-29: 5.4M2024-03-15: 5.8M2024-03-28: 6.5M2024-04-15: 6.9M2024-04-30: 7.5M2024-05-15: 7.8M2024-05-31: 8.6M
    the 31 May 2024 report24 earlier reportsnormal: 6.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  20. 21 Mar 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  21. 21 Mar 2024Filings record

    Director or officer change

  22. 27 Apr 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  23. 27 Apr 2023Filings record

    Director or officer change

  24. 29 Mar 2023Filings record

    Restructuring costs announced

  25. 5 Oct 2022Filings record

    Director or officer change

  26. 23 Sep 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  27. 23 Sep 2022Filings record

    Director or officer change

  28. 9 Aug 2022Financials change

    reported revenue of $79.9M for the quarter ended 30 Jun 2022, 12× the same quarter last year.

    Same quarter last year: $6.6M; its normal quarter is $6.2M.

    See the evidence
    This period
    $79.9M (the quarter ended 30 Jun 2022)
    Normal quarter (median of 8 earlier)
    $6.2M
    Typical spread (median absolute deviation)
    $2.6M
    How far from its usual level
    +19.1
    Same quarter last year
    $6.6M
    History used
    1,552 days
    2020-06-30: $3.2M2020-09-30: $5.9M2020-12-31: $4.9M2021-03-31: $4.1M2021-06-30: $6.6M2021-09-30: $182.4M2021-12-31: $14.0M2022-03-31: $24.5M2022-06-30: $79.9M
    the quarter ended 30 Jun 20228 earlier quartersnormal: $6.2M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  29. 10 May 2022Financials change

    reported revenue of $24.5M for the quarter ended 31 Mar 2022, 6.0× the same quarter last year.

    Same quarter last year: $4.1M; its normal quarter is $6.2M.

    See the evidence
    This period
    $24.5M (the quarter ended 31 Mar 2022)
    Normal quarter (median of 8 earlier)
    $6.2M
    Typical spread (median absolute deviation)
    $1.8M
    How far from its usual level
    +7.0
    Same quarter last year
    $4.1M
    History used
    1,461 days
    2020-03-31: $7.2M2020-06-30: $3.2M2020-09-30: $5.9M2020-12-31: $4.9M2021-03-31: $4.1M2021-06-30: $6.6M2021-09-30: $182.4M2021-12-31: $14.0M2022-03-31: $24.5M
    the quarter ended 31 Mar 20228 earlier quartersnormal: $6.2M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  30. 29 Mar 2022Filings record

    Director or officer change

  31. 1 Mar 2022Financials change

    reported revenue of $14.0M for the quarter ended 31 Dec 2021, 2.9× the same quarter last year.

    Same quarter last year: $4.9M; its normal quarter is $6.0M.

    See the evidence
    This period
    $14.0M (the quarter ended 31 Dec 2021)
    Normal quarter (median of 8 earlier)
    $6.0M
    Typical spread (median absolute deviation)
    $1.2M
    How far from its usual level
    +4.7
    Same quarter last year
    $4.9M
    History used
    1,371 days
    2019-12-31: $6.0M2020-03-31: $7.2M2020-06-30: $3.2M2020-09-30: $5.9M2020-12-31: $4.9M2021-03-31: $4.1M2021-06-30: $6.6M2021-09-30: $182.4M2021-12-31: $14.0M
    the quarter ended 31 Dec 20218 earlier quartersnormal: $6.0M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  32. 7 Feb 2022Filings record

    Director or officer change

  33. 3 Jan 2022Filings record

    Director or officer change

  34. 3 Jan 2022Filings record

    Director or officer change

  35. 15 Dec 2021Filings record

    Director or officer change

  36. 9 Nov 2021Financials change

    reported revenue of $182.4M for the quarter ended 30 Sep 2021, 31× the same quarter last year.

    Same quarter last year: $5.9M; its normal quarter is $5.4M.

    See the evidence
    This period
    $182.4M (the quarter ended 30 Sep 2021)
    Normal quarter (median of 8 earlier)
    $5.4M
    Typical spread (median absolute deviation)
    $1.2M
    How far from its usual level
    +97.2
    Same quarter last year
    $5.9M
    History used
    1,279 days
    2019-09-30: $2.7M2019-12-31: $6.0M2020-03-31: $7.2M2020-06-30: $3.2M2020-09-30: $5.9M2020-12-31: $4.9M2021-03-31: $4.1M2021-06-30: $6.6M2021-09-30: $182.4M
    the quarter ended 30 Sep 20218 earlier quartersnormal: $5.4M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  37. 28 Sep 2021Filings record

    Director or officer change

  38. 8 Sep 2021Filings record

    Director or officer change

  39. 7 Sep 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  40. 7 Sep 2021Filings record

    Director or officer change

Showing the newest 40 of 62 entries; narrow the window or the kind of data to see older ones.

Not listed: 229 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001653087
Ticker
ALEC
Domain
alector.com
Employer name
Alector, LLC (1 unverified)
Hq location
CA|SOUTH SAN FRANCISCO|94080 (1 unverified)
Name
Alector, Inc.
Uei
SATPQJ1CRZN3
Wikidata
Q61934361
  • DOL H-1B labor condition applications and PERM certifications57 data points11 Jan 2021 to 3 Nov 2025
  • SEC Form 13F institutional holdings279 data points31 Mar 2019 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)120 records7 Jan 2019 to 5 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)568 data points31 Dec 2016 to 30 Oct 2026
  • SEC Form 4 insider transactions147 records, 356 data points11 Feb 2019 to 4 Sep 2026
  • FINRA short interest (twice monthly)554 data points15 Feb 2019 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)3918 data points7 Feb 2019 to 20 Nov 2026
  • USASpending.gov federal awards9 data points7 Sep 2015 to 14 Sep 2018